Corrado Advisors’s UnitedHealth UNH Stock Holding History

Corrado Advisors’s Portfolio UNH Stock Details UNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-871	Closed	-$439K	–	118
2023 Q3	$439K	Buy	+871	New	+$429K	0.3%	83
2023 Q2	–	Sell	-991	Closed	-$468K	–	114
2023 Q1	$468K	Sell	991 -5	-0.5%	-$2.41K	0.31%	84
2022 Q4	$528K	Buy	+996	New	+$528K	0.37%	79

Other funds holding UNH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Corrado Advisors's UNH Position: Q4 2023 in Review

Corrado Advisors sold out of UnitedHealth (UNH) in Q4 2023, closing a stake of 871 shares — an estimated $439K sold.

Corrado Advisors first reported a position in UNH in Q4 2022 and held it in 3 quarters. The position peaked at $528K in Q4 2022. 3,411 funds tracked by Wall St. Rank hold UNH as of Q4 2023.

Corrado Advisors reported no remaining UnitedHealth position as of Q4 2023 after selling out during the quarter.
Corrado Advisors sold 871 UnitedHealth shares in Q4 2023, an estimated $439K.
Corrado Advisors first reported a position in UnitedHealth in Q4 2022 and held it in 3 quarters.
Corrado Advisors's UnitedHealth position peaked at $528K in Q4 2022.
3,411 funds tracked by Wall St. Rank held UnitedHealth as of Q4 2023.

Based on Corrado Advisors's 13F filing for Q4 2023, filed 1 Feb 2024.